These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 453106)

  • 1. Effect of oral contraceptives on antithrombin III measurement.
    Petersen C; Kelly R; Minard B; Cawley LP
    Am J Clin Pathol; 1979 Jul; 72(1):134-5. PubMed ID: 453106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological coagulation inhibitors (protein S, protein C and antithrombin III) in severe preeclamptic states and in users of oral contraceptives.
    Gilabert J; Fernandez JA; España F; Aznar J; Estelles A
    Thromb Res; 1988 Feb; 49(3):319-29. PubMed ID: 2966452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin inhibitors in women on oral contraceptives.
    Guagnellini E; Bertolini G; Cappelletti M; Colombo G
    Acta Haematol; 1981; 65(3):205-10. PubMed ID: 6165217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect or oral contraceptives on antithrombin III.
    McEntee MP; Jesty J; Hultin MB
    Thromb Res; 1981 Oct 1-15; 24(1-2):13-20. PubMed ID: 6800055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of oral contraceptives on folate metabolism. III. Plasma clearance and urinary folate excretion.
    Shojania AM; Hornady GJ; Scaletta D
    J Lab Clin Med; 1975 Feb; 85(2):185-90. PubMed ID: 1113011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of posture and saline loading on plasma renin activity and aldosterone concentration in pregnant, non-pregnant and estrogen-treated women.
    Weinberger MH; Kramer NJ; Grim CE; Petersen LP
    J Clin Endocrinol Metab; 1977 Jan; 44(1):69-77. PubMed ID: 833263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral alanine loads on plasma amino acids in oral contraceptive users and control women.
    Potera C; Rose DP
    Am J Clin Nutr; 1978 May; 31(5):794-8. PubMed ID: 645627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between levels of blood lipids, vitamins C, A, and E, serum copper compounds, and urinary excretions of tryptophan metabolites in women taking oral contraceptive therapy.
    Horwitt MK; Harvey CC; Dahm CH
    Am J Clin Nutr; 1975 Apr; 28(4):403-12. PubMed ID: 1119436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma antithrombin III activity in normal pregnancy.
    Weiner CP; Brandt J
    Obstet Gynecol; 1980 Nov; 56(5):601-3. PubMed ID: 7432731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of oral contraceptive agents on nutrients: II. Vitamins.
    Prasad AS; Oberleas D; Moghissi KS; Stryker JC; Lei KY
    Am J Clin Nutr; 1975 Apr; 28(4):385-91. PubMed ID: 1168019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex hormone binding globulin: effect of synthetic steroids on the assay and effect of oral contraceptives.
    Bowles SM; Mills RJ
    Ann Clin Biochem; 1981 Jul; 18(Pt 4):226-31. PubMed ID: 7197136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zinc and copper nutriture of women taking oral contraceptive agents.
    Vir SC; Love AH
    Am J Clin Nutr; 1981 Aug; 34(8):1479-83. PubMed ID: 6791490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oral alanine loads on the serum triglycerides of oral contraceptive users and normal subjects.
    Rose DP; Leklem JE; Fardal L; Baron RB; Shrago E
    Am J Clin Nutr; 1977 May; 30(5):691-4. PubMed ID: 855811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oral contraceptive agents and antithrombin III].
    Kamenov V; Nalbanski B
    Akush Ginekol (Sofiia); 1990; 29(1):60-3. PubMed ID: 1695492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active and inactive renin in pregnancy and in women on estrogen-containing oral contraceptives.
    Hayashi M; Saruta T; Nakamura R; Saito I; Kondo K; Kato E
    Gynecol Obstet Invest; 1979; 10(5):246-53. PubMed ID: 395034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oestrogen containing oral contraceptives and antithrombin III activity.
    Rákóczi I; Nagy I; Szigetvári I; Losonczy H; Hadnagy J; Gáti I
    Acta Physiol Acad Sci Hung; 1974; 45(3-4):281-6. PubMed ID: 4471272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombin 3 depression and thrombin generation acceleration in women taking oral contraceptives.
    Von Kaulla E; Droegemueller W; Aoki N; Von Kaulla KN
    Am J Obstet Gynecol; 1971 Mar; 109(6):868-73. PubMed ID: 5552623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the prethrombotic state in pregnancy and in women using oral contraceptives.
    Levine AB; Teppa J; McGough B; Cowchock FS
    Contraception; 1996 May; 53(5):255-7. PubMed ID: 8724613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The change of antithrombin III activity of pregnant women and women on oral contraceptives (author's transl)].
    Ogura H; Miyaji K; Kinoshita T; Aoki N
    Nihon Ketsueki Gakkai Zasshi; 1977 Apr; 40(2):232-7. PubMed ID: 578068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in haemostasis after stopping the combined contraceptive pill: implications for major surgery.
    Robinson GE; Burren T; Mackie IJ; Bounds W; Walshe K; Faint R; Guillebaud J; Machin SJ
    BMJ; 1991 Feb; 302(6771):269-71. PubMed ID: 1998792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.